Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
moraxellaceae infections
MeSH D045828 - moraxellaceae infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D016905:
Gram-negative bacterial infections
29 Companies
14 Drugs
$
Success rate
D045828:
Moraxellaceae infections
27 Companies
7 Drugs
$
Success rate
D000151:
Acinetobacter infections
42 Companies
12 Drugs
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
No data
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Cefdinir
,
Cefprozil
Sandoz
Cefdinir
,
Cefprozil
Eli Lilly
Cephalexin
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use
